Amar Kelkar | Harvard Catalyst Profiles

Cornell University College of Agriculture and Life Sciences, Ithaca, NY	BS	05/2010	Biological Sciences, Genetics & Development
St. George's University School of Medicine, True Blue, Grenada, WI	MD	05/2015	Doctor of Medicine
University of Illinois College of Medicine, Peoria, IL		06/2018	Residency in Internal Medicine
University of Florida College of Medicine, Gainesville, FL		06/2021	Fellowship in Hematology & Oncology
Harvard T.H. Chan School of Public Health, Boston, MA		08/2021	Program in Clinical Effectiveness
Dana-Farber Cancer Institute, Boston, MA		08/2022	Advanced Fellowship in Stem Cell Transplantation
Harvard T.H. Chan School of Public Health, Boston, MA	MPH	11/2023	Clinical Effectiveness

awards and honors

2022

ASCO Annual Meeting Merit Award Recipient

2024 - 2026

ASTCT New Investigator Award

Overview

overview

Dr. Amar Kelkar is a Stem Cell Transplantation Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical School. He sees patients for allogeneic transplantation and cell and gene therapy, treating many blood disorders including leukemia and sickle cell disease. He also directs the BMT Survivorship Clinic.

He is a member of the Abel Laboratory with research interests in hematology, care delivery, health economics, medical ethics, public health, and health policy. He completed an MPH in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health in 2023 and received the ASTCT New Investigator Award in 2024. His work has been published in journals including the New England Journal of Medicine, Annals of Internal Medicine, and the Journal of Clinical Oncology, as well as in STAT Opinion. He also has interests in health policy and medical advocacy and serves on the American Society of Hematology Committee on Practice and Subcommittee on Reimbursement, the American Society for Transplantation and Cellular Therapy Value and Health Economics Special Interest Group, and the Massachusetts Medical Society (MMS) Committee on Publications that oversees the NEJM Group. He previously served on the MMS Board of Trustees, the American Medical Association (AMA) Council on Legislation, and was the AMA Resident and Fellow Section Governing Council Delegate to the House of Delegates.

His background is in molecular biology and genetics with a degree from Cornell University in Biological Sciences, where he worked for 3 years as a member of the Andrew Clark Laboratory focused on population genetics. He completed postgraduate medical training at the University of Illinois College of Medicine at Peoria, the University of Florida College of Medicine, and the Dana-Farber Cancer Institute.

keywords

media links

	'Poisoning is not on your radar': In report, doctors describe cases of illness caused by 'fake weed' (09/26/2018)
	A New Source of “Superwarfarin” Poisoning: Increased Bleeding Risk After Synthetic Cannabinoid Use (12/01/2018)
	Big Ideas on Burnout: Trainees Propose System-Wide Solutions (01/2021)
	Specialized centers can help realign the U.S.’s moral compass for sickle cell disease (12/22/2022)
	Ethical Concerns Raised by Oncology Researchers Regarding Patient-Facing Artificial Intelligence (11/05/2023)
	Patient-Facing AI in Cancer Care (11/07/2023)
	As Biden invokes wartime powers to regulate AI, oncology braces for fundamental change (11/17/2023)
	CAR T-Cell Therapy May Be Effective—but Unaffordable—as Second-Line Therapy for Patients With DLBCL (12/06/2023)
	What doctors wish patients knew about iron deficiency (01/26/2024)

Featured Content

Twitter

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

This operation might take several minutes to complete. Please do not close your browser.

Year	Publications
2016	2
2017	3
2018	1
2019	1
2020	6
2021	8
2022	8
2023	14
2024	1

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.

Kelkar's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (108)

Explore

Co-Authors (37)

Explore

Similar People (60)

Explore

Same Department

Explore